STOCK TITAN

[Form 4] MANNKIND CORP Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4

Stuart A. Tross, Chief People & Workpl Officer at MannKind Corp (MNKD), reported the sale of 47,000 shares on 09/16/2025 under a Rule 10b5-1 trading plan established June 17, 2025. The weighted average sales price was $5.34 per share (price range $5.33–$5.39). After the reported sale, Mr. Tross beneficially owned 1,032,013 shares. The filing is a routine Section 16 Form 4 disclosing an insider sale executed pursuant to a pre-established trading plan.

Stuart A. Tross, Chief People & Workpl Officer di MannKind Corp (MNKD), ha riportato la vendita di 47.000 azioni il 16/09/2025 nell'ambito di un piano di trading Rule 10b5-1 istituito il 17 giugno 2025. Il prezzo medio ponderato di vendita è stato di 5,34 USD per azione (intervallo di prezzo 5,33–5,39). Dopo la vendita comunicata, il signor Tross possedeva beneficiariamente 1.032.013 azioni. La documentazione è un normale modulo Sezione 16 Form 4 che rende pubblica una vendita interna effettuata in conformità a un piano di trading predefinito.

Stuart A. Tross, Director de Personas y Trabajo en MannKind Corp (MNKD), informó la venta de 47,000 acciones el 16/09/2025 bajo un plan de trading Rule 10b5-1 establecido el 17 de junio de 2025. El precio medio ponderado de venta fue de 5,34 USD por acción (rango de precios 5,33–5,39). Tras la venta reportada, el Sr. Tross poseía beneficiosamente 1.032.013 acciones. El registro es un formulario rutinario Sección 16 Form 4 que divulga una venta insider realizada conforme a un plan de trading preestablecido.

MannKind Corp(MNKD)의 Chief People & Workpl Officer인 Stuart A. Tross가 2025년 6월 17일에 제정된 Rule 10b5-1 거래 계획에 따라 2025년 9월 16일 47,000주를 매도했다고 보고했습니다. 가중 평균 매도가격은 주당 5.34달러였으며(가격 범위 5.33–5.39). 보고된 매도 후 Tross씨는 유익하게도 1,032,013주를 보유했습니다. 이 공시는 사전 설정된 거래 계획에 따라 수행된 내부자 매도를 공개하는 일반적인 섹션 16 양식 4의 제출입니다.

Stuart A. Tross, Chief People & Workpl Officer chez MannKind Corp (MNKD), a signalé la vente de 47 000 actions le 16/09/2025 dans le cadre d'un plan de négociation Rule 10b5-1 établi le 17 juin 2025. Le prix de vente moyen pondéré était de 5,34 USD par action (plage de prix 5,33–5,39). Après la vente signalée, M. Tross détenait avantageusement 1 032 013 actions. Le dépôt est un formulaire courant de la Section 16 Form 4 divulguant une vente interne effectuée conformément à un plan de trading préétabli.

Stuart A. Tross, Chief People & Workpl Officer bei MannKind Corp (MNKD), meldete den Verkauf von 47.000 Aktien am 16.09.2025 im Rahmen eines Rule 10b5-1-Handelsplans, der am 17.06.2025 festgelegt wurde. Der gewichtete durchschnittliche Verkaufspreis betrug 5,34 USD pro Aktie (Preisspanne 5,33–5,39). Nach dem gemeldeten Verkauf besaß Herr Tross vorteilhaft 1.032.013 Aktien. Die Einreichung ist ein routinemäßiges Section 16 Form 4, das einen Insider-Verkauf offenlegt, der gemäß einem vorab festgelegten Handelsplan durchgeführt wurde.

ستاندرت أ. تروس، رئيس قسم الأشخاص والعمل في MannKind Corp (MNKD)، أبلغ عن بيع 47,000 سهم في 16/09/2025 بموجب خطة تداول Rule 10b5-1 التي أُنشئت في 17 يونيو 2025. كان سعر البيع المتوسط المرجح 5.34 دولاراً أمريكياً للسهم الواحد (نطاق الأسعار من 5.33 إلى 5.39). وبعد البيع المبلغ عنه، امتلك السيد تروس بشكل مستفيد 1,032,013 سهمًا. الإيداع هو نموذج قسم 16 Form 4 روتيني يكشف عن بيع داخلي تم تنفيذه وفق خطة تداول محددة سلفاً.

Stuart A. Tross,MannKind Corp(MNKD)的首席人力与工作场所官员,已在2025年9月16日按照于2025年6月17日设立的10b5-1交易计划出售了47,000股。 加权平均销售价为每股5.34美元(价格区间5.33–5.39美元)。在此次交易后,Tross先生实际持有1,032,013股。该披露属于常规的第16条Form 4表格,披露依预先设定的交易计划执行的内部人出售。

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider sold 47,000 shares under a 10b5-1 plan; still holds over 1.03M shares, indicating ongoing meaningful ownership.

The transaction is a disclosed, rule-compliant insider sale rather than an ad hoc disposition. The use of a Rule 10b5-1 plan (established June 17, 2025) reduces concerns about contemporaneous material nonpublic information influencing the trade. The weighted average sale price was $5.34, with the total post-transaction beneficial ownership at 1,032,013 shares, which remains a significant stake relative to typical insider positions in small-cap issuers. For investors, this is a routine liquidity event rather than clear directional signal about company fundamentals.

TL;DR: Properly documented 10b5-1 sale demonstrates adherence to governance procedures; transaction disclosure is complete.

The filing includes the required details: transaction date, number of shares sold, price range, and the 10b5-1 plan establishment date. The signer manually executed the Form 4. From a governance standpoint, the clear linkage to a pre-established plan and the precise pricing range support compliance with insider trading rules. There is no indication in the filing of other derivative transactions or amendments.

Stuart A. Tross, Chief People & Workpl Officer di MannKind Corp (MNKD), ha riportato la vendita di 47.000 azioni il 16/09/2025 nell'ambito di un piano di trading Rule 10b5-1 istituito il 17 giugno 2025. Il prezzo medio ponderato di vendita è stato di 5,34 USD per azione (intervallo di prezzo 5,33–5,39). Dopo la vendita comunicata, il signor Tross possedeva beneficiariamente 1.032.013 azioni. La documentazione è un normale modulo Sezione 16 Form 4 che rende pubblica una vendita interna effettuata in conformità a un piano di trading predefinito.

Stuart A. Tross, Director de Personas y Trabajo en MannKind Corp (MNKD), informó la venta de 47,000 acciones el 16/09/2025 bajo un plan de trading Rule 10b5-1 establecido el 17 de junio de 2025. El precio medio ponderado de venta fue de 5,34 USD por acción (rango de precios 5,33–5,39). Tras la venta reportada, el Sr. Tross poseía beneficiosamente 1.032.013 acciones. El registro es un formulario rutinario Sección 16 Form 4 que divulga una venta insider realizada conforme a un plan de trading preestablecido.

MannKind Corp(MNKD)의 Chief People & Workpl Officer인 Stuart A. Tross가 2025년 6월 17일에 제정된 Rule 10b5-1 거래 계획에 따라 2025년 9월 16일 47,000주를 매도했다고 보고했습니다. 가중 평균 매도가격은 주당 5.34달러였으며(가격 범위 5.33–5.39). 보고된 매도 후 Tross씨는 유익하게도 1,032,013주를 보유했습니다. 이 공시는 사전 설정된 거래 계획에 따라 수행된 내부자 매도를 공개하는 일반적인 섹션 16 양식 4의 제출입니다.

Stuart A. Tross, Chief People & Workpl Officer chez MannKind Corp (MNKD), a signalé la vente de 47 000 actions le 16/09/2025 dans le cadre d'un plan de négociation Rule 10b5-1 établi le 17 juin 2025. Le prix de vente moyen pondéré était de 5,34 USD par action (plage de prix 5,33–5,39). Après la vente signalée, M. Tross détenait avantageusement 1 032 013 actions. Le dépôt est un formulaire courant de la Section 16 Form 4 divulguant une vente interne effectuée conformément à un plan de trading préétabli.

Stuart A. Tross, Chief People & Workpl Officer bei MannKind Corp (MNKD), meldete den Verkauf von 47.000 Aktien am 16.09.2025 im Rahmen eines Rule 10b5-1-Handelsplans, der am 17.06.2025 festgelegt wurde. Der gewichtete durchschnittliche Verkaufspreis betrug 5,34 USD pro Aktie (Preisspanne 5,33–5,39). Nach dem gemeldeten Verkauf besaß Herr Tross vorteilhaft 1.032.013 Aktien. Die Einreichung ist ein routinemäßiges Section 16 Form 4, das einen Insider-Verkauf offenlegt, der gemäß einem vorab festgelegten Handelsplan durchgeführt wurde.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Tross Stuart A

(Last) (First) (Middle)
1 CASPER STREET

(Street)
DANBURY CT 06810

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MANNKIND CORP [ MNKD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief People & Workpl Officer
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.01 Par Value 09/16/2025 S(1) 47,000 D $5.34(2) 1,032,013 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Transaction occured pursuant to Rule 10B5-1 Plan established June 17, 2025.
2. The weighted average sales price of the reported transaction was $5.34 based on a range of prices between $5.33 and $5.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
/s/ Stuart A. Tross 09/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stuart A. Tross report on Form 4 for MNKD?

The filing reports a sale of 47,000 shares on 09/16/2025 under a Rule 10b5-1 plan and shows 1,032,013 shares beneficially owned after the transaction.

Was the MNKD insider transaction part of a pre-established trading plan?

Yes. The sale occurred pursuant to a Rule 10b5-1 plan established on June 17, 2025.

At what price were the MNKD shares sold in the reported transaction?

The weighted average sales price was $5.34, with a reported price range of $5.33 to $5.39.

How much MNKD stock does the reporting person own after the sale?

After the reported sale, the reporting person beneficially owned 1,032,013 shares.

Does the Form 4 indicate any derivative transactions for MNKD by the reporting person?

No. Table II is blank and the filing discloses only the non-derivative sale in Table I.
Mannkind

NASDAQ:MNKD

MNKD Rankings

MNKD Latest News

MNKD Latest SEC Filings

MNKD Stock Data

1.72B
301.53M
1.66%
55.86%
5.18%
Biotechnology
Pharmaceutical Preparations
Link
United States
DANBURY